Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic Cancer

20 Sept 2018

Abstract excerpt

Individuals at risk (IAR) of familial pancreatic cancer (FPC) are good candidates for screening. Unfortunately, neither reliable imaging modalities nor biomarkers are available to detect high-grade precursor lesions or early cancer. Circulating levels of candidate biomarkers LCN2, TIMP1, Glypican-1, RNU2-1f, and miRNA-196b were analyzed in 218 individuals with sporadic pancreatic ductal adenocarcinoma (PDAC, n =...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Pancreatic and Hepatic Oncology Research
Share to Renal and related cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30241369
DOI: 10.3390/jcm7100295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Combination of MiRNA-196b, LCN2, and TIMP1 is a Potential Set of Circulating Biomarkers for Screening Individuals at Risk for Familial Pancreatic CancerPMID 30241369Read ↗

Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort studySemantic proximity Read ↗

Sequencing Pancreatic Juice: Squeezing the Most Out of Surveillance.Semantic proximity Read ↗

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneﬁcial?Semantic proximity Read ↗

Prospective markers for early diagnosis and prognosis of sporadic pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities.Semantic proximity Read ↗

Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.Semantic proximity Read ↗

Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohortsSemantic proximity Read ↗

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancerSemantic proximity Read ↗

Plasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studySemantic proximity Read ↗

Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals.Semantic proximity Read ↗

Short-term Results of a Magnetic Resonance Imaging-Based Swedish Screening Program for Individuals at Risk for Pancreatic Cancer.Semantic proximity Read ↗

Differential signature of fecal microRNAs in patients with pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.